User login
What treatments are effective for varicose veins?
For larger trunk varicose veins, as in the saphenous vein, therapeutic options include conservative measures (such as leg elevation and compression stockings), injection sclerotherapy, and surgical vein ligation, with or without stripping.Long-term outcomes appear superior with surgical treatment.
For mid-sized reticular veins and spider telangiectasias, several options are available, including sclerotherapy, laser ablation, and thermal ablation. However, no randomized trials have compared the relative effectiveness of these treatments.
Venotonic medications (primarily plantderived and synthetic flavonoids, such as horse chestnut seed extract, that improve venous tone) provide symptom relief. Head-to-head comparisons are needed to identify the most efficacious therapies (strength of recommendation: C, based on case series and extrapolations from small trials.)
Evidence summary
Graduated elastic compression stockings improve lower-extremity hemodynamics (including reflux and residual volume measured by color flow duplex scanning) in patients with varicosities, and can improve symptoms such as swelling, discomfort, and leg tightness.1,2
A Cochrane review concluded that existing evidence supports the use of sclerotherapy for recurrent varicose veins after surgery and for relatively minor “thread” veins.3 Data did not show that any particular type of sclerosant or pressure dressing or duration of post-treatment compression have significant effect on outcomes, such as disappearance of varicosities and cosmetic improvement.3
A Cochrane protocol is in progress regarding comparison of the outcomes of surgery and sclerotherapy.4 Few randomized trials have compared surgery and sclerotherapy.
Belcaro reported results of a 10-year randomized trial including 121 subjects, 96 of whom completed the study.5 Surgery consisted of ligation of the saphenopopliteal junction without stripping. At 10 years, 16.1% of patients receiving surgery plus sclerotherapy had distal venous incompetence (assessed with color duplex scanning and ambulatory venous pressure measurement), compared with 36.4% of those who underwent surgery alone and 43.8% of those who received sclerotherapy alone. The authors concluded that long-term outcomes (defined as saphenofemoral junction competence) are superior with strategies that included surgery, but at greater cost.
Beresford and colleagues also concluded that surgery lessened the likelihood of additional treatment.6 Another randomized trial showed that saphenous vein stripping reduced by two thirds the need for reoperation due to recurrent saphenofemoral incompetence, compared with saphenofemoral junction ligation alone.7
A meta-analysis studied the effectiveness of venotonic medications (such as rutoside, flunarizine, and dihydroergotamine) in chronic venous insufficiency.8 These agents significantly reduced pain, leg heaviness, cramps, and paresthesias. However, a Cochrane Collaboration reviewer questioned the validity of pooling results from this heterogeneous group of studies into a single meta-analysis.9
A Cochrane Review did find that horse chestnut seed extract significantly improves leg pain, edema, pruritus, and lower leg volume and circumference, but suggests that larger randomized trials are needed to establish conclusively this agent’s efficacy.10
Recommendations from others
A recent clinical review indicated that patients whose main symptoms are swelling or aching can be treated with compression stockings alone; trunk varicosities should be treated with saphenofemoral or saphenopopliteal ligation, plus stripping of the long saphenous vein for long saphenous varicosities.11 They suggest that sclerotherapy should be reserved for varicosities that persist after surgery.
The Venous Insufficiency Epidemiologic and Economic Studies (VEINES) program recommends sclerotherapy for telangiectasias and reticular veins, and surgery for saphenous varicosities.12 However, they noted the need for randomized trials to compare therapies.
Alan Adelman, MD, MS
Penn State University, State College, Pa
Choosing the best treatment for varicose veins can be complicated. Symptoms and the type of varicose veins (truncal varices, reticular varices, or telangiectasia) can guide the clinician in selecting therapy. Asymptomatic varicosities can usually be observed without treatment. Patients with symptomatic varicosities may be treated conservatively before referring for invasive treatment.
Surgery is probably the best treatment for truncal varices, whereas sclerotherapy is better for reticular veins or telangiectasia. The long-term risks and benefits of newer modalities such as laser and thermal ablation need further evaluation. Regardless of the treatment chosen, patients with varicose veins should first undergo a thorough investigation.
1. Weiss RA, Duffy D. Clinical benefits of lightweight compression: reduction of venous-related symptoms by ready-to-wear lightweight gradient compression hosiery. Dermatol Surg 1999;25:701-704.
2. Labropoulos N, Leon M, Volteas N, Nicolaides AN. Acute and long-term effect of elastic stockings in patients with varicose veins. Int Angiol 1994;13:119-123.
3. Tisi PV, Beverley CA. Injection sclerotherapy for varicose veins (Cochrane Review). In: The Cochrane Library, Issue 2, 2002. Oxford: Update Software.
4. Michaels JA, Kendall RJ. Surgery for varicose veins (Protocol for a Cochrane Review). In: The Cochrane Library, Issue 2, 2002. Oxford: Update Software.
5. Belcaro G, Nicolaides AN, Ricci A, et al. Endovascular sclerotherapy, surgery, and surgery plus sclerotherapy in superficial venous incompetence: a randomized, 10-year follow-up trial—final results. Angiology 2000;51:529-534.
6. Beresford SAA, Chant ADB, Jones HO, Piachaud D, Weddell JM. Varicose veins: a comparison of surgery and injection/compression sclerotherapy. Five-year follow-up. Lancet. 1978;1:921-924.
7. Dwerryhouse S, Davies B, Harradine K, Earnshaw JJ. Stripping the long saphenous vein reduces the rate of reoperation for recurrent varicose veins: five-year results of a randomized trial. J Vasc Surg 1999;29:589-592.
8. Boada JN, Nazco GJ. Therapeutic effect of venotonics in chronic venous insufficiency: a meta-analysis. Clin Drug Invest 1999;18:413-432.
9. Therapeutic effect of venotonics in chronic venous insufficiency: a meta-analysis In: The Cochrane Library, Issue 2, 2002. Oxford: Update Software.
10. Pittler MH, Ernst E. Horse chestnut seed extract for chronic venous insufficiency (Cochrane Review). In: The Cochrane Library, Issue 2, 2002. Oxford: Update Software.
11. London NJM, Nash R. ABC of arterial and venous disease. Varicose veins. BMJ 2000;320:1391-1394.
12. Kurz X, Kahn SR, Abenhaim L, et al. Chronic venous disorders of the leg: epidemiology, outcomes, diagnosis and management. Summary of an evidence-based report of the VEINES task force. Int Angiol 1999;18:83-102.
For larger trunk varicose veins, as in the saphenous vein, therapeutic options include conservative measures (such as leg elevation and compression stockings), injection sclerotherapy, and surgical vein ligation, with or without stripping.Long-term outcomes appear superior with surgical treatment.
For mid-sized reticular veins and spider telangiectasias, several options are available, including sclerotherapy, laser ablation, and thermal ablation. However, no randomized trials have compared the relative effectiveness of these treatments.
Venotonic medications (primarily plantderived and synthetic flavonoids, such as horse chestnut seed extract, that improve venous tone) provide symptom relief. Head-to-head comparisons are needed to identify the most efficacious therapies (strength of recommendation: C, based on case series and extrapolations from small trials.)
Evidence summary
Graduated elastic compression stockings improve lower-extremity hemodynamics (including reflux and residual volume measured by color flow duplex scanning) in patients with varicosities, and can improve symptoms such as swelling, discomfort, and leg tightness.1,2
A Cochrane review concluded that existing evidence supports the use of sclerotherapy for recurrent varicose veins after surgery and for relatively minor “thread” veins.3 Data did not show that any particular type of sclerosant or pressure dressing or duration of post-treatment compression have significant effect on outcomes, such as disappearance of varicosities and cosmetic improvement.3
A Cochrane protocol is in progress regarding comparison of the outcomes of surgery and sclerotherapy.4 Few randomized trials have compared surgery and sclerotherapy.
Belcaro reported results of a 10-year randomized trial including 121 subjects, 96 of whom completed the study.5 Surgery consisted of ligation of the saphenopopliteal junction without stripping. At 10 years, 16.1% of patients receiving surgery plus sclerotherapy had distal venous incompetence (assessed with color duplex scanning and ambulatory venous pressure measurement), compared with 36.4% of those who underwent surgery alone and 43.8% of those who received sclerotherapy alone. The authors concluded that long-term outcomes (defined as saphenofemoral junction competence) are superior with strategies that included surgery, but at greater cost.
Beresford and colleagues also concluded that surgery lessened the likelihood of additional treatment.6 Another randomized trial showed that saphenous vein stripping reduced by two thirds the need for reoperation due to recurrent saphenofemoral incompetence, compared with saphenofemoral junction ligation alone.7
A meta-analysis studied the effectiveness of venotonic medications (such as rutoside, flunarizine, and dihydroergotamine) in chronic venous insufficiency.8 These agents significantly reduced pain, leg heaviness, cramps, and paresthesias. However, a Cochrane Collaboration reviewer questioned the validity of pooling results from this heterogeneous group of studies into a single meta-analysis.9
A Cochrane Review did find that horse chestnut seed extract significantly improves leg pain, edema, pruritus, and lower leg volume and circumference, but suggests that larger randomized trials are needed to establish conclusively this agent’s efficacy.10
Recommendations from others
A recent clinical review indicated that patients whose main symptoms are swelling or aching can be treated with compression stockings alone; trunk varicosities should be treated with saphenofemoral or saphenopopliteal ligation, plus stripping of the long saphenous vein for long saphenous varicosities.11 They suggest that sclerotherapy should be reserved for varicosities that persist after surgery.
The Venous Insufficiency Epidemiologic and Economic Studies (VEINES) program recommends sclerotherapy for telangiectasias and reticular veins, and surgery for saphenous varicosities.12 However, they noted the need for randomized trials to compare therapies.
Alan Adelman, MD, MS
Penn State University, State College, Pa
Choosing the best treatment for varicose veins can be complicated. Symptoms and the type of varicose veins (truncal varices, reticular varices, or telangiectasia) can guide the clinician in selecting therapy. Asymptomatic varicosities can usually be observed without treatment. Patients with symptomatic varicosities may be treated conservatively before referring for invasive treatment.
Surgery is probably the best treatment for truncal varices, whereas sclerotherapy is better for reticular veins or telangiectasia. The long-term risks and benefits of newer modalities such as laser and thermal ablation need further evaluation. Regardless of the treatment chosen, patients with varicose veins should first undergo a thorough investigation.
For larger trunk varicose veins, as in the saphenous vein, therapeutic options include conservative measures (such as leg elevation and compression stockings), injection sclerotherapy, and surgical vein ligation, with or without stripping.Long-term outcomes appear superior with surgical treatment.
For mid-sized reticular veins and spider telangiectasias, several options are available, including sclerotherapy, laser ablation, and thermal ablation. However, no randomized trials have compared the relative effectiveness of these treatments.
Venotonic medications (primarily plantderived and synthetic flavonoids, such as horse chestnut seed extract, that improve venous tone) provide symptom relief. Head-to-head comparisons are needed to identify the most efficacious therapies (strength of recommendation: C, based on case series and extrapolations from small trials.)
Evidence summary
Graduated elastic compression stockings improve lower-extremity hemodynamics (including reflux and residual volume measured by color flow duplex scanning) in patients with varicosities, and can improve symptoms such as swelling, discomfort, and leg tightness.1,2
A Cochrane review concluded that existing evidence supports the use of sclerotherapy for recurrent varicose veins after surgery and for relatively minor “thread” veins.3 Data did not show that any particular type of sclerosant or pressure dressing or duration of post-treatment compression have significant effect on outcomes, such as disappearance of varicosities and cosmetic improvement.3
A Cochrane protocol is in progress regarding comparison of the outcomes of surgery and sclerotherapy.4 Few randomized trials have compared surgery and sclerotherapy.
Belcaro reported results of a 10-year randomized trial including 121 subjects, 96 of whom completed the study.5 Surgery consisted of ligation of the saphenopopliteal junction without stripping. At 10 years, 16.1% of patients receiving surgery plus sclerotherapy had distal venous incompetence (assessed with color duplex scanning and ambulatory venous pressure measurement), compared with 36.4% of those who underwent surgery alone and 43.8% of those who received sclerotherapy alone. The authors concluded that long-term outcomes (defined as saphenofemoral junction competence) are superior with strategies that included surgery, but at greater cost.
Beresford and colleagues also concluded that surgery lessened the likelihood of additional treatment.6 Another randomized trial showed that saphenous vein stripping reduced by two thirds the need for reoperation due to recurrent saphenofemoral incompetence, compared with saphenofemoral junction ligation alone.7
A meta-analysis studied the effectiveness of venotonic medications (such as rutoside, flunarizine, and dihydroergotamine) in chronic venous insufficiency.8 These agents significantly reduced pain, leg heaviness, cramps, and paresthesias. However, a Cochrane Collaboration reviewer questioned the validity of pooling results from this heterogeneous group of studies into a single meta-analysis.9
A Cochrane Review did find that horse chestnut seed extract significantly improves leg pain, edema, pruritus, and lower leg volume and circumference, but suggests that larger randomized trials are needed to establish conclusively this agent’s efficacy.10
Recommendations from others
A recent clinical review indicated that patients whose main symptoms are swelling or aching can be treated with compression stockings alone; trunk varicosities should be treated with saphenofemoral or saphenopopliteal ligation, plus stripping of the long saphenous vein for long saphenous varicosities.11 They suggest that sclerotherapy should be reserved for varicosities that persist after surgery.
The Venous Insufficiency Epidemiologic and Economic Studies (VEINES) program recommends sclerotherapy for telangiectasias and reticular veins, and surgery for saphenous varicosities.12 However, they noted the need for randomized trials to compare therapies.
Alan Adelman, MD, MS
Penn State University, State College, Pa
Choosing the best treatment for varicose veins can be complicated. Symptoms and the type of varicose veins (truncal varices, reticular varices, or telangiectasia) can guide the clinician in selecting therapy. Asymptomatic varicosities can usually be observed without treatment. Patients with symptomatic varicosities may be treated conservatively before referring for invasive treatment.
Surgery is probably the best treatment for truncal varices, whereas sclerotherapy is better for reticular veins or telangiectasia. The long-term risks and benefits of newer modalities such as laser and thermal ablation need further evaluation. Regardless of the treatment chosen, patients with varicose veins should first undergo a thorough investigation.
1. Weiss RA, Duffy D. Clinical benefits of lightweight compression: reduction of venous-related symptoms by ready-to-wear lightweight gradient compression hosiery. Dermatol Surg 1999;25:701-704.
2. Labropoulos N, Leon M, Volteas N, Nicolaides AN. Acute and long-term effect of elastic stockings in patients with varicose veins. Int Angiol 1994;13:119-123.
3. Tisi PV, Beverley CA. Injection sclerotherapy for varicose veins (Cochrane Review). In: The Cochrane Library, Issue 2, 2002. Oxford: Update Software.
4. Michaels JA, Kendall RJ. Surgery for varicose veins (Protocol for a Cochrane Review). In: The Cochrane Library, Issue 2, 2002. Oxford: Update Software.
5. Belcaro G, Nicolaides AN, Ricci A, et al. Endovascular sclerotherapy, surgery, and surgery plus sclerotherapy in superficial venous incompetence: a randomized, 10-year follow-up trial—final results. Angiology 2000;51:529-534.
6. Beresford SAA, Chant ADB, Jones HO, Piachaud D, Weddell JM. Varicose veins: a comparison of surgery and injection/compression sclerotherapy. Five-year follow-up. Lancet. 1978;1:921-924.
7. Dwerryhouse S, Davies B, Harradine K, Earnshaw JJ. Stripping the long saphenous vein reduces the rate of reoperation for recurrent varicose veins: five-year results of a randomized trial. J Vasc Surg 1999;29:589-592.
8. Boada JN, Nazco GJ. Therapeutic effect of venotonics in chronic venous insufficiency: a meta-analysis. Clin Drug Invest 1999;18:413-432.
9. Therapeutic effect of venotonics in chronic venous insufficiency: a meta-analysis In: The Cochrane Library, Issue 2, 2002. Oxford: Update Software.
10. Pittler MH, Ernst E. Horse chestnut seed extract for chronic venous insufficiency (Cochrane Review). In: The Cochrane Library, Issue 2, 2002. Oxford: Update Software.
11. London NJM, Nash R. ABC of arterial and venous disease. Varicose veins. BMJ 2000;320:1391-1394.
12. Kurz X, Kahn SR, Abenhaim L, et al. Chronic venous disorders of the leg: epidemiology, outcomes, diagnosis and management. Summary of an evidence-based report of the VEINES task force. Int Angiol 1999;18:83-102.
1. Weiss RA, Duffy D. Clinical benefits of lightweight compression: reduction of venous-related symptoms by ready-to-wear lightweight gradient compression hosiery. Dermatol Surg 1999;25:701-704.
2. Labropoulos N, Leon M, Volteas N, Nicolaides AN. Acute and long-term effect of elastic stockings in patients with varicose veins. Int Angiol 1994;13:119-123.
3. Tisi PV, Beverley CA. Injection sclerotherapy for varicose veins (Cochrane Review). In: The Cochrane Library, Issue 2, 2002. Oxford: Update Software.
4. Michaels JA, Kendall RJ. Surgery for varicose veins (Protocol for a Cochrane Review). In: The Cochrane Library, Issue 2, 2002. Oxford: Update Software.
5. Belcaro G, Nicolaides AN, Ricci A, et al. Endovascular sclerotherapy, surgery, and surgery plus sclerotherapy in superficial venous incompetence: a randomized, 10-year follow-up trial—final results. Angiology 2000;51:529-534.
6. Beresford SAA, Chant ADB, Jones HO, Piachaud D, Weddell JM. Varicose veins: a comparison of surgery and injection/compression sclerotherapy. Five-year follow-up. Lancet. 1978;1:921-924.
7. Dwerryhouse S, Davies B, Harradine K, Earnshaw JJ. Stripping the long saphenous vein reduces the rate of reoperation for recurrent varicose veins: five-year results of a randomized trial. J Vasc Surg 1999;29:589-592.
8. Boada JN, Nazco GJ. Therapeutic effect of venotonics in chronic venous insufficiency: a meta-analysis. Clin Drug Invest 1999;18:413-432.
9. Therapeutic effect of venotonics in chronic venous insufficiency: a meta-analysis In: The Cochrane Library, Issue 2, 2002. Oxford: Update Software.
10. Pittler MH, Ernst E. Horse chestnut seed extract for chronic venous insufficiency (Cochrane Review). In: The Cochrane Library, Issue 2, 2002. Oxford: Update Software.
11. London NJM, Nash R. ABC of arterial and venous disease. Varicose veins. BMJ 2000;320:1391-1394.
12. Kurz X, Kahn SR, Abenhaim L, et al. Chronic venous disorders of the leg: epidemiology, outcomes, diagnosis and management. Summary of an evidence-based report of the VEINES task force. Int Angiol 1999;18:83-102.
Evidence-based answers from the Family Physicians Inquiries Network
Primary Data for Primary Care
“Doc, I just feel tired all the time.” How do we primary care clinicians respond to a complaint like this? Generally we create a mental picture of patients we have seen like this in the past and attempt to recall the spectrum of disorders we have encountered that can present with fatigue as a chief complaint. We then seek additional patient information to further characterize the fatigue and identify associated symptoms. Whether we realize it or not, we are revising the probability of specific diagnoses on the basis of the original complaint and each new piece of information. For example, learning that a young woman has had heavy periods might lead us to suspect iron-deficiency anemia; pallor anemia in a fatigued 65-year-old man might lead us to suspect colon cancer.
In this issue of JFP, Okkes and colleagues1 have studied primary care outpatient practices to identify the distribution of diagnoses that a particular complaint, such as fatigue, might represent. These prior probabilities of disease can be used in 2 ways: (1) to interpret the likelihood of a disorder in view of new information, such as a laboratory result or answer to additional question; and (2) to help the clinician prioritize where she should concentrate her efforts in evaluating the patient’s complaint.
The first technique involves the use of Bayes’ theorem to revise the probability of disease in light of new information. For a woman aged 25 years to 44 years, the prior probability for depression as the source for tiredness, according to Table 3 in the Okkes et al article, is approximatley 1.3%. This information can then be used to interpret the results of additional questioning and screening instruments. For example, the Short Depression Screen (SDS) is a brief 8-item instrument that is 86% sensitive and 90% specific.2 The positive likelihood ratio (sensitivity/1-specificity) tells us how well a positive test result rules-in disease, and in this case is 8.6. This number can then be used with readily available nomograms to estimate the post-test probability that the patient has depression.3 An abnormal SDS result in our tired woman increases the likelihood of depression to approximately 15% — a 10-fold increase in our certainty about the underlying cause for her tiredness. The information Okkes et al have provided therefore serves as the substrate for interpreting additional information that we attain in the clinical interaction This information also provides us with qualitative guidance in focusing our history, physical, and laboratory examinations. Returning again to Table 3, we see that iron-deficiency anemia, depressive disorder, and several psychosocial diagnoses dominate the rankings. This gives us an idea about how we should focus our clinical queries in a patient who complains of fatigue. While we have access to diagnosis frequency information from other sources, such as the National Ambulatory Medical Care Survey,4 stratification by presenting complaint corresponds to how we actually care for our patients.
Ultimately, as more clinicians use an electronic medical record, we will have access to similar data specific to our practices.5 Data collected automatically, collated, continuously updated, and maintained in databases will be available to support, in real time, the kind of semi-quantitative decision support functions described above. Additionally, evidence-based guidelines can be incorporated into these systems to provide clinical decision support tailored to the practice. Unfortunately, such systems are not yet widely available in physicians’ offices.6 In the absence of such clinical information systems, the data Okkes and colleagues have given us will substantively enhance our ability to optimize clinical decision making in our ambulatory practice environments.
REFERENCE
1. Okkes IM, Oskam SK, Lamberts H. J Fam Pract 2002;51:31-36.
2. Burnam A, Wells KB, Leake B, Landsverk J. Medical Care 1988;26:775-89.
3. Fagan TJ. New Eng J Med 1975;293:257.-
4. Cherry DK, Burt CW, Woodwell DA. National Ambulatory Medical Care Survey: 1999 summary. Advance data from vital and health statistics; no. 322. Hyattsville, Maryland: National Center for Health Statistics. 2001.
5. Sim I, Gorman P, Greenes RA, et al. J Am Med Informatics Assoc 2001;8:527-34.
6. Barrett MJ. Healthcare Informatics May 2000;85.-
“Doc, I just feel tired all the time.” How do we primary care clinicians respond to a complaint like this? Generally we create a mental picture of patients we have seen like this in the past and attempt to recall the spectrum of disorders we have encountered that can present with fatigue as a chief complaint. We then seek additional patient information to further characterize the fatigue and identify associated symptoms. Whether we realize it or not, we are revising the probability of specific diagnoses on the basis of the original complaint and each new piece of information. For example, learning that a young woman has had heavy periods might lead us to suspect iron-deficiency anemia; pallor anemia in a fatigued 65-year-old man might lead us to suspect colon cancer.
In this issue of JFP, Okkes and colleagues1 have studied primary care outpatient practices to identify the distribution of diagnoses that a particular complaint, such as fatigue, might represent. These prior probabilities of disease can be used in 2 ways: (1) to interpret the likelihood of a disorder in view of new information, such as a laboratory result or answer to additional question; and (2) to help the clinician prioritize where she should concentrate her efforts in evaluating the patient’s complaint.
The first technique involves the use of Bayes’ theorem to revise the probability of disease in light of new information. For a woman aged 25 years to 44 years, the prior probability for depression as the source for tiredness, according to Table 3 in the Okkes et al article, is approximatley 1.3%. This information can then be used to interpret the results of additional questioning and screening instruments. For example, the Short Depression Screen (SDS) is a brief 8-item instrument that is 86% sensitive and 90% specific.2 The positive likelihood ratio (sensitivity/1-specificity) tells us how well a positive test result rules-in disease, and in this case is 8.6. This number can then be used with readily available nomograms to estimate the post-test probability that the patient has depression.3 An abnormal SDS result in our tired woman increases the likelihood of depression to approximately 15% — a 10-fold increase in our certainty about the underlying cause for her tiredness. The information Okkes et al have provided therefore serves as the substrate for interpreting additional information that we attain in the clinical interaction This information also provides us with qualitative guidance in focusing our history, physical, and laboratory examinations. Returning again to Table 3, we see that iron-deficiency anemia, depressive disorder, and several psychosocial diagnoses dominate the rankings. This gives us an idea about how we should focus our clinical queries in a patient who complains of fatigue. While we have access to diagnosis frequency information from other sources, such as the National Ambulatory Medical Care Survey,4 stratification by presenting complaint corresponds to how we actually care for our patients.
Ultimately, as more clinicians use an electronic medical record, we will have access to similar data specific to our practices.5 Data collected automatically, collated, continuously updated, and maintained in databases will be available to support, in real time, the kind of semi-quantitative decision support functions described above. Additionally, evidence-based guidelines can be incorporated into these systems to provide clinical decision support tailored to the practice. Unfortunately, such systems are not yet widely available in physicians’ offices.6 In the absence of such clinical information systems, the data Okkes and colleagues have given us will substantively enhance our ability to optimize clinical decision making in our ambulatory practice environments.
“Doc, I just feel tired all the time.” How do we primary care clinicians respond to a complaint like this? Generally we create a mental picture of patients we have seen like this in the past and attempt to recall the spectrum of disorders we have encountered that can present with fatigue as a chief complaint. We then seek additional patient information to further characterize the fatigue and identify associated symptoms. Whether we realize it or not, we are revising the probability of specific diagnoses on the basis of the original complaint and each new piece of information. For example, learning that a young woman has had heavy periods might lead us to suspect iron-deficiency anemia; pallor anemia in a fatigued 65-year-old man might lead us to suspect colon cancer.
In this issue of JFP, Okkes and colleagues1 have studied primary care outpatient practices to identify the distribution of diagnoses that a particular complaint, such as fatigue, might represent. These prior probabilities of disease can be used in 2 ways: (1) to interpret the likelihood of a disorder in view of new information, such as a laboratory result or answer to additional question; and (2) to help the clinician prioritize where she should concentrate her efforts in evaluating the patient’s complaint.
The first technique involves the use of Bayes’ theorem to revise the probability of disease in light of new information. For a woman aged 25 years to 44 years, the prior probability for depression as the source for tiredness, according to Table 3 in the Okkes et al article, is approximatley 1.3%. This information can then be used to interpret the results of additional questioning and screening instruments. For example, the Short Depression Screen (SDS) is a brief 8-item instrument that is 86% sensitive and 90% specific.2 The positive likelihood ratio (sensitivity/1-specificity) tells us how well a positive test result rules-in disease, and in this case is 8.6. This number can then be used with readily available nomograms to estimate the post-test probability that the patient has depression.3 An abnormal SDS result in our tired woman increases the likelihood of depression to approximately 15% — a 10-fold increase in our certainty about the underlying cause for her tiredness. The information Okkes et al have provided therefore serves as the substrate for interpreting additional information that we attain in the clinical interaction This information also provides us with qualitative guidance in focusing our history, physical, and laboratory examinations. Returning again to Table 3, we see that iron-deficiency anemia, depressive disorder, and several psychosocial diagnoses dominate the rankings. This gives us an idea about how we should focus our clinical queries in a patient who complains of fatigue. While we have access to diagnosis frequency information from other sources, such as the National Ambulatory Medical Care Survey,4 stratification by presenting complaint corresponds to how we actually care for our patients.
Ultimately, as more clinicians use an electronic medical record, we will have access to similar data specific to our practices.5 Data collected automatically, collated, continuously updated, and maintained in databases will be available to support, in real time, the kind of semi-quantitative decision support functions described above. Additionally, evidence-based guidelines can be incorporated into these systems to provide clinical decision support tailored to the practice. Unfortunately, such systems are not yet widely available in physicians’ offices.6 In the absence of such clinical information systems, the data Okkes and colleagues have given us will substantively enhance our ability to optimize clinical decision making in our ambulatory practice environments.
REFERENCE
1. Okkes IM, Oskam SK, Lamberts H. J Fam Pract 2002;51:31-36.
2. Burnam A, Wells KB, Leake B, Landsverk J. Medical Care 1988;26:775-89.
3. Fagan TJ. New Eng J Med 1975;293:257.-
4. Cherry DK, Burt CW, Woodwell DA. National Ambulatory Medical Care Survey: 1999 summary. Advance data from vital and health statistics; no. 322. Hyattsville, Maryland: National Center for Health Statistics. 2001.
5. Sim I, Gorman P, Greenes RA, et al. J Am Med Informatics Assoc 2001;8:527-34.
6. Barrett MJ. Healthcare Informatics May 2000;85.-
REFERENCE
1. Okkes IM, Oskam SK, Lamberts H. J Fam Pract 2002;51:31-36.
2. Burnam A, Wells KB, Leake B, Landsverk J. Medical Care 1988;26:775-89.
3. Fagan TJ. New Eng J Med 1975;293:257.-
4. Cherry DK, Burt CW, Woodwell DA. National Ambulatory Medical Care Survey: 1999 summary. Advance data from vital and health statistics; no. 322. Hyattsville, Maryland: National Center for Health Statistics. 2001.
5. Sim I, Gorman P, Greenes RA, et al. J Am Med Informatics Assoc 2001;8:527-34.
6. Barrett MJ. Healthcare Informatics May 2000;85.-